Simultaneous MLPA-based multiplex point mutation and deletion analysis of the dystrophin gene.
The Multiplex Ligation-dependent Probe Amplification assay (MLPA) is the method of choice for the initial mutation screen in the analysis of a large number of genes where partial or total gene deletion is part of the mutation spectrum. Although MLPA dosage probes are usually designed to bind to norm...
Main Authors: | Bunyan, D, Skinner, A, Ashton, E, Sillibourne, J, Brown, T, Collins, A, Cross, N, Harvey, J, Robinson, DO |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
A new approach for the identification of common point mutations within the dystrophin gene using MLPA
by: Skinner, A, et al.
Published: (2005) -
MLPA-based point mutation analysis of the FBN1 gene in Marfan syndrome patients.
by: Bunyan, D, et al.
Published: (2004) -
MLPA identification of dystrophin mutations and in silico evaluation of the predicted protein in dystrophinopathy cases from India
by: Sekar Deepha, et al.
Published: (2017-06-01) -
MLPA followed by target‐NGS to detect mutations in the dystrophin gene of Peruvian patients suspected of DMD/DMB
by: María Luisa Guevara‐Fujita, et al.
Published: (2021-09-01) -
Characterisation of beta globin gene cluster deletions using multiplex-Gap-PCR and Multiplex Ligation-dependent Probe Amplification (MLPA)
by: Redzuwan, Yasmin Mohamad
Published: (2018)